Publications by authors named "Franziska Schauer"

Article Synopsis
  • Recessive dystrophic epidermolysis bullosa (RDEB) is a severe skin condition that causes blisters and other complications, and this study tested the safety of losartan, a medication that may slow its progression.
  • The study was a phase 1/2 trial involving children aged 2-16 with confirmed RDEB, focusing on identifying any serious side effects of losartan over a treatment period of 10 months.
  • Primary safety concerns monitored included severe drops in blood pressure, allergic reactions, and changes in potassium levels, along with evaluating the drug's effectiveness through various clinical scores.
View Article and Find Full Text PDF
Article Synopsis
  • There is currently no established treatment for Eosinophilic Lichen Planus (ELP), and standard therapies for cutaneous Lichen Planus (LP), like retinoids, are ineffective in ELP cases.
  • Topical glucocorticosteroids can help in some cases of esophageal inflammation but are not always effective, leading to the trial of various immunosuppressive therapies with mixed results.
  • The report highlights a severe ELP case that was resistant to multiple treatments, but significant improvement was achieved with the JAK inhibitor tofacitinib, suggesting its potential role in treating this immune-mediated condition.
View Article and Find Full Text PDF

We describe a case of endocarditis caused by Streptobacillus moniliformis bacteria, a known cause of rat-bite fever, in a 32-year-old woman with pet rats in Germany. The patient had a strong serologic response, with high IgM and IgG titers. Serologic analysis is a promising tool to identify S.

View Article and Find Full Text PDF

Background: Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are potentially life-threatening autoimmune blistering diseases. Treatment is based on long-term immunosuppression with high doses of glucocorticosteroids in combination with potentially corticosteroid-sparing agents and/or rituximab. Immunoadsorption (IA) has emerged as a fast-acting adjuvant treatment option.

View Article and Find Full Text PDF

Bullous pemphigoid (BP) is an autoimmune blistering disease that primarily affects the elderly. An altered skin microbiota in BP was recently revealed. Accumulating evidence points toward a link between the gut microbiota and skin diseases; however, the gut microbiota composition of BP patients remains largely underexplored, with only one pilot study to date, with a very limited sample size and no functional profiling of gut microbiota.

View Article and Find Full Text PDF

Background: The occurrence of herpes zoster is rising globally. Future trends will be influenced by changes in population demographics and the growing number of patients at risk. Overall this poses a challenge for healthcare systems.

View Article and Find Full Text PDF

Introduction: Psoriasis (Pso) and psoriatic arthritis (PsA) can reduce the quality of life (QoL) and are known to be associated with depression. Within this study, we aimed to assess the burden of disease, functional capacity, quality of life, and depressive symptoms and identify factors predicting functional impairment and depression in patients with psoriatic disease.

Methods: A cross-sectional survey was conducted in a cohort of 300 patients with psoriatic disease including 150 patients from a university hospital dermatology outpatient clinic and 150 patients from a university hospital rheumatology outpatient clinic.

View Article and Find Full Text PDF

An involvement of the esophagus in patients with lichen planus was described for the first time in 1982. Ever since, it has been seen as a rarity. However, studies over the last 10 years have shown a higher prevalence than expected.

View Article and Find Full Text PDF

Pemphigoid diseases are a group of autoimmune disorders characterized by subepidermal blistering in the skin and mucosa. Among them, mucous membrane pemphigoid (MMP) autoantibodies are characterized by targeting multiple molecules in the hemidesmosomes, including collagen XVII, laminin-332, and integrin a6/β4. Traditionally, recombinant proteins of the autoantigens have been employed to identify circulating autoantibodies by immune assays.

View Article and Find Full Text PDF

Introduction: Dermatitis herpetiformis (DH) is a rare autoimmune, polymorphous blistering disorder, characterized by severe itch or burning sensation, which represents the cutaneous manifestation of celiac disease (CD). The current estimation of DH versus CD is around 1:8 and the affected individuals have a genetic predisposition. Pathogenetically, IgA autoantibodies against the epidermal transglutaminase, an essential constituent of the epidermis, cause DH and are reported to develop through cross-reaction with the tissue transglutaminase, with IgA auto-antibodies causing CD.

View Article and Find Full Text PDF
Article Synopsis
  • Epidermolysis bullosa (EB) is a rare genetic disorder causing fragile skin and painful blisters, leading to serious complications like chronic wounds and squamous cell carcinoma.
  • The EASE study was a phase III trial that tested Oleogel-S10, a topical gel with birch triterpenes, for improving wound healing in patients with different forms of EB.
  • Results showed that 41.3% of patients using Oleogel-S10 achieved complete wound closure within 45 days, compared to 28.9% with a control gel, indicating that Oleogel-S10 is effective and well-tolerated for treating wounds in EB patients.
View Article and Find Full Text PDF

Introduction: Autoimmune bullous diseases (AIBD) are a heterogeneous group of rare autoantibody-mediated blistering dermatoses of the skin and/or mucous membranes. Their incidence is around 20 new cases per million inhabitants per year in Germany. Patients with chronic, oncological, or rare diseases often urge for a holistic therapeutic approach that includes complementary and alternative medicine (CAM).

View Article and Find Full Text PDF
Article Synopsis
  • - A middle-aged Italian man with a long history of psoriasis and psoriasis arthropathica was treated with adalimumab, a medication approved for psoriasis in individuals aged 4 and older.
  • - He developed ulcers or nodules in the psoriatic plaques, which appeared similar to a skin infection, potentially linked to a disruption in the immune response.
  • - The infection resolved after the discontinuation of adalimumab, indicating that stopping anti-TNF treatment was sufficient, and no specific medication was needed for the infection.
View Article and Find Full Text PDF

A male patient presented to our department at the age of 23 suffering from recurrent painful erosions in the urethral outlet area. In closer clinical examination gingival erosions, primarily around the teeth were identified as well. Indirect immunofluorescence on salt split skin with epidermal IgG deposition and positive anti-BP230 IgG ELISA diagnostics hinted toward the presence of mucous membrane pemphigoid (MMP).

View Article and Find Full Text PDF

Lichen planus (LP) is a frequent, chronic inflammatory disease involving the skin, mucous membranes and/or skin appendages. Esophageal involvement in lichen planus (ELP) is a clinically important albeit underdiagnosed inflammatory condition. This narrative review aims to give an overview of the current knowledge on ELP, its prevalence, pathogenesis, clinical manifestation, diagnostic criteria, and therapeutic options in order to provide support in clinical management.

View Article and Find Full Text PDF

Immune checkpoint inhibitors (ICI) induce T-cell-mediated antitumour responses. While ICI were initially successfully applied in metastasized melanoma, they are now approved for several tumour entities. Numerous autoimmune disorders have been reported to occur as adverse events of the treatment, among them bullous pemphigoid (BP), with less than 1% of the patients experiencing ICI-induced BP.

View Article and Find Full Text PDF

Importance: Bullous pemphigoid is a difficult-to-treat autoimmune blistering skin disease that predominantly affects older adults and is associated with an increased mortality rate.

Objective: To examine the safety and therapeutic potential of nomacopan, an inhibitor of leukotriene B4 and complement C5, in patients with bullous pemphigoid.

Design, Setting, And Participants: This multicenter, single-group, phase 2a nonrandomized controlled trial was conducted in the dermatology departments of universities in the Netherlands and Germany.

View Article and Find Full Text PDF

Collagen VII is the main constituent of the anchoring fibrils, important adhesive structures that attach the epidermis to the dermal extracellular matrix. Two disorders are caused by dysfunction of collagen VII, both characterized by skin and mucosa fragility, epidermolysis bullosa acquisita (EBA) and dystrophic epidermolysis bullosa (DEB). EBA and DEB share high clinical similarities with significant difference in patients' age of onset and pathogenesis.

View Article and Find Full Text PDF

This case series characterizes immune profiles of pregnant people with pemphigoid gestationis.

View Article and Find Full Text PDF